Watson Pharmaceuticals Acquires Arrow Group

You may not have heard of either company if you do not keep up with the generic drug market, but Watson Pharmaceuticals has shelled out $1.75 billion for the Arrow Group. This will allow Watson to fulfill its plan of expanding internationally once it had taken control of its rival and formed a company large enough to handle such a move.
 
The takeover is significant for Watson, which will gain a company that dealt with $647 million in revenue last year. It will also allow Watson to tap into the Arrow Groups markets in over twenty countries, expediting its plan to …read more